New Study Asks Why Lupus Patients Don’t Take Their Hydroxychloroquine
The Rheumatologist reports on the findings of a retrospective study which evaluated adult systemic lupus erythematosus (SLE) patients and their adherence to hydroxychloroquine (HCQ) therapy. Findings indicate adherence is a complex behavior, and is not only about access to care, but also patients’ relationship with their rheumatologists. Additionally, patient concern over side effects (i.e., long-term retinal toxicity), and the discontinuation of the medication when patients feel it isn’t working, may also play a role.
The Rheumatologist spoke to Doruk Erkan, MD, MPH, who provided commentary on the findings, stating, “The [study] findings help us better predict the risk of medication non-compliance while managing lupus patients.”
Read the full article at the-rheumatologist.org.